Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
OP Bancorp
OPBK
$233M
| $1.13M | ﹤0.01% |
113,331
+1,235
| +1% | +$12.9K |
|
3327
Comp X International
CIX
$371M
| $1.11M | ﹤0.01% |
32,390
+2,369
| +8% | +$63K |
|
|
JKS
3328
JinkoSolar
JKS
$891M
| $1.11M | ﹤0.01% |
44,014
+1,831
| +4% | +$50.3K |
|
3329
Lantronix
LTRX
$266M
| $1.1M | ﹤0.01% |
310,128
+3,295
| +1% | +$16.2K |
|
3330
Nuvectis Pharma
NVCT
$617M
| $1.1M | ﹤0.01% |
134,528
+2,871
| +2% | +$24.4K |
|
3331
Electromed
ELMD
$349M
| $1.1M | ﹤0.01% |
68,288
+6,394
| +10% | +$84.2K |
|
3332
Hudbay
HBM
$12.3B
| $1.09M | ﹤0.01% |
155,607
-10,158
| -6% | -$59.1K |
|
3333
Transcontinental Realty Investors
TCI
$323M
| $1.09M | ﹤0.01% |
29,034
-466
| -2% | -$18.1K |
|
|
SBDS
3334
DELISTED
Solo Brands Inc
SBDS
| $1.09M | ﹤0.01% |
12,586
-452
| -3% | -$51.9K |
|
|
SCTL
3335
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.09M | ﹤0.01% |
1,010,684
+73,150
| +8% | +$47.1K |
|
|
MNTX
3336
DELISTED
Manitex International, Inc.
MNTX
| $1.09M | ﹤0.01% |
158,259
+8,204
| +5% | +$59.8K |
|
3337
Beyond Air
XAIR
$3.86M
| $1.08M | ﹤0.01% |
1,553
+164
| +12% | +$113K |
|
3338
AstroNova
ALOT
$227M
| $1.07M | ﹤0.01% |
59,797
+740
| +1% | +$12.9K |
|
3339
Delcath Systems
DCTH
$524M
| $1.06M | ﹤0.01% |
223,005
+53,403
| +31% | +$230K |
|
3340
OPAL Fuels
OPAL
$70.7M
| $1.06M | ﹤0.01% |
211,797
+4,021
| +2% | +$19.7K |
|
3341
Torrid Holdings
CURV
$260M
| $1.06M | ﹤0.01% |
216,946
+5,579
| +3% | +$27.5K |
|
|
LFT
3342
Lument Finance Trust
LFT
$36.6M
| $1.06M | ﹤0.01% |
423,759
+4,975
| +1% | +$11.7K |
|
|
VRNA
3343
DELISTED
Verona Pharma
VRNA
| $1.05M | ﹤0.01% |
65,372
+4,259
| +7% | +$73.6K |
|
|
SCX
3344
DELISTED
The L.S. Starrett Company
SCX
| $1.05M | ﹤0.01% |
66,013
+1,687
| +3% | +$21.8K |
|
3345
VEON
VEON
$3.95B
| $1.04M | ﹤0.01% |
43,388
+104
| +0.2% | +$2.32K |
|
3346
Northern Technologies International Corp
NTIC
$80M
| $1.04M | ﹤0.01% |
77,266
+944
| +1% | +$12.5K |
|
|
MDV
3347
Modiv Industrial
MDV
$187M
| $1.04M | ﹤0.01% |
61,768
-5,127
| -8% | -$76.8K |
|
|
AISP
3348
Airship AI Holdings
AISP
$71.3M
| $1.04M | ﹤0.01% |
157,333
+135,101
| +608% | +$496K |
|
|
CMRX
3349
DELISTED
Chimerix, Inc.
CMRX
| $1.03M | ﹤0.01% |
972,799
+60,039
| +7% | +$62.5K |
|
3350
Fossil Group
FOSL
$318M
| $1.03M | ﹤0.01% |
1,007,666
-7,540
| -0.7% | -$8.41K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.